FDX1 and nonpapillary renal cell carcinoma: Yang and Zhang et al. proved that FDX1 was downregulated in various cancers, including ccRCC, and overexpression of FDX1 could repress the malignant tumor phenotype in ccRCC, and vice versa [42, 43].